Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.41 | $0 | -$1M |
| 2026 Q1 | -0.38 | $0 | -$1M |
| 2025 Q4 | -0.73 | $3,000 | -$2M |
| 2025 Q3 | -0.48 | $0 | -$1M |
| 2025 Q2 | -0.48 | $0 | -$1M |
| 2025 Q1 | -0.83 | $3,000 | -$2M |
| 2024 Q4 |
| -1.12 |
| $3,000 |
| -$2M |
| 2024 Q3 | -0.75 | $0 | -$985,590 |